11:58 AM EST - Medicago Inc. : announced that it has entered into a research collaboration agreement with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) for the development of a plant-based VLP vaccine candidate for the prevention of Ebola. Ebola is a very serious hemorrhagic fever virus for which no licensed treatment or vaccine exists. Medicago Inc.
shares T.MDG are trading up $0.01 at $0.51.
